329 related articles for article (PubMed ID: 16326671)
1. Landiolol and esmolol prevent tachycardia without altering cerebral blood flow.
Saito S; Nishihara F; Akihiro T; Nishikawa K; Obata H; Goto F; Yuki N
Can J Anaesth; 2005 Dec; 52(10):1027-34. PubMed ID: 16326671
[TBL] [Abstract][Full Text] [Related]
2. Landiolol attenuates acute hemodynamic responses but does not reduce seizure duration during maintenance electroconvulsive therapy.
Sakamoto A; Ogawa R; Suzuki H; Kimura M; Okubo Y; Fujiya T
Psychiatry Clin Neurosci; 2004 Dec; 58(6):630-5. PubMed ID: 15601388
[TBL] [Abstract][Full Text] [Related]
3. The hemodynamic effects of landiolol, an ultra-short-acting beta1-selective blocker, on endotracheal intubation in patients with and without hypertension.
Sugiura S; Seki S; Hidaka K; Masuoka M; Tsuchida H
Anesth Analg; 2007 Jan; 104(1):124-9. PubMed ID: 17179256
[TBL] [Abstract][Full Text] [Related]
4. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol.
Sasao J; Tarver SD; Kindscher JD; Taneyama C; Benson KT; Goto H
Can J Anaesth; 2001 Nov; 48(10):985-9. PubMed ID: 11698317
[TBL] [Abstract][Full Text] [Related]
5. Optimal dose of landiolol for preventing abrupt changes in both cardiac output and middle cerebral artery flow velocity after electroconvulsive therapy.
Kadoi Y; Saito S
J ECT; 2014 Sep; 30(3):224-6. PubMed ID: 24755725
[TBL] [Abstract][Full Text] [Related]
6. Bolus administration of landiolol, a short-acting, selective beta1-blocker, to treat tachycardia during anesthesia: a dose-dependent study.
Harasawa R; Hayashi Y; Iwasaki M; Kamibayashi T; Mashimo T
J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):793-5. PubMed ID: 17138082
[TBL] [Abstract][Full Text] [Related]
7. [New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].
Mio Y
Masui; 2006 Jul; 55(7):841-8. PubMed ID: 16856544
[TBL] [Abstract][Full Text] [Related]
8. Prolongation of QT interval induced by electroconvulsive therapy is attenuated by landiolol.
Matsura M; Fujiwara Y; Ito H; Kandatsu N; Kato N; Harada J; Komatsu T
J ECT; 2010 Mar; 26(1):37-40. PubMed ID: 20190601
[TBL] [Abstract][Full Text] [Related]
9. Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity.
Yamakage M; Iwasaki S; Jeong SW; Satoh J; Namiki A
Heart Lung; 2009; 38(1):48-55. PubMed ID: 19150530
[TBL] [Abstract][Full Text] [Related]
10. Effect of esmolol pretreatment on EEG seizure morphology in RUL ECT.
McCall WV; Zvara D; Brooker R; Arias L
Convuls Ther; 1997 Sep; 13(3):175-80. PubMed ID: 9342133
[TBL] [Abstract][Full Text] [Related]
11. Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts.
Kurosawa S; Kanaya N; Niiyama Y; Nakayama M; Fujita S; Namiki A
Can J Anaesth; 2003 May; 50(5):489-94. PubMed ID: 12734159
[TBL] [Abstract][Full Text] [Related]
12. Esmolol bolus and infusion attenuates increases in blood pressure and heart rate during electroconvulsive therapy.
Kovac AL; Goto H; Arakawa K; Pardo MP
Can J Anaesth; 1990 Jan; 37(1):58-62. PubMed ID: 1967227
[TBL] [Abstract][Full Text] [Related]
13. Esmolol and landiolol, selective beta1-adrenoreceptor antagonists, provide neuroprotection against spinal cord ischemia and reperfusion in rats.
Umehara S; Goyagi T; Nishikawa T; Tobe Y; Masaki Y
Anesth Analg; 2010 Apr; 110(4):1133-7. PubMed ID: 20103544
[TBL] [Abstract][Full Text] [Related]
14. Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study.
Xiao J; He P; Zou Q; Zhao Y; Xue Z; Deng X; Li S; Guo Q; Tao G; Yang T; Lang Z; He J; Wang X
J Clin Anesth; 2015 Mar; 27(2):120-8. PubMed ID: 25434501
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of esmolol and labetalol to attenuate haemodynamic responses after electroconvulsive therapy.
Shrestha S; Shrestha BR; Thapa C; Pradhan SN; Thapa R; Adhikari S
Kathmandu Univ Med J (KUMJ); 2007; 5(3):318-23. PubMed ID: 18604047
[TBL] [Abstract][Full Text] [Related]
16. Effects of landiolol on hemodynamic response and seizure duration during electroconvulsive therapy.
Nomoto K; Suzuki T; Serada K; Oe K; Yoshida T; Yamada S
J Anesth; 2006; 20(3):183-7. PubMed ID: 16897237
[TBL] [Abstract][Full Text] [Related]
17. The effect of esmolol on ST-segment depression and arrhythmias after electroconvulsive therapy.
Zvara DA; Brooker RF; McCall WV; Foreman AS; Hewitt C; Murphy BA; Royster RL
Convuls Ther; 1997 Sep; 13(3):165-74. PubMed ID: 9342132
[TBL] [Abstract][Full Text] [Related]
18. [Beta-blockers and electroconvulsive therapy: a review].
van den Broek WW; Groenland TH; Mulder PG; Kusuma A; Birkenhäger TK; Pluijms EM; Bruijn JA
Tijdschr Psychiatr; 2008; 50(4):205-15. PubMed ID: 18398800
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of landiolol in attenuating hemodynamic responses to local epinephrine infiltration in patients undergoing vaginal total hysterectomy.
Hirota K; Baba S; Fukushi S; Muraoka M; Matsuki A
J Anesth; 2005; 19(1):17-20. PubMed ID: 15674510
[TBL] [Abstract][Full Text] [Related]
20. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: I. Effectiveness of pretreatment regimens on hemodynamics.
Weinger MB; Partridge BL; Hauger R; Mirow A
Anesth Analg; 1991 Nov; 73(5):556-62. PubMed ID: 1952135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
